Evidence map›Paper›PMID 30411018›Full record

ArticleACS omega2018

Intracellular Delivery of Gold Nanocolloids Promoted by a Chemically Conjugated Anticancer Peptide.

Anshika Kapur, Scott H Medina, Wentao Wang, Goutam Palui, Joel P Schneider, Hedi Mattoussi

Abstract read
In one paragraph

Article in ACS omega, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anshika KapurDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida 32306, United States.
Scott H MedinaCenter for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
Wentao WangDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida 32306, United States.
Goutam PaluiDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida 32306, United States.
Joel P SchneiderCenter for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
Hedi MattoussiDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida 32306, United States.

Funding

Development of antibacterial agents and materialsZIABC011314 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNEIDER, JOEL · 2010 to 2025
$8.9M
Regulation of Metabolism and the Impact of Obesity for Olfactory SignalingR01DC013080 · NIDCD · FLORIDA STATE UNIVERSITY · PI FADOOL, DEBRA ANN · 2014 to 2017
$1.2M
NIDCD NIH HHS R01 DC013080
6 · The paper itself

Abstract

We report on the ability of a chemically synthesized anticancer peptide, SVS-1, to promote the rapid uptake of gold nanorods (AuNRs) and gold nanoparticles (AuNPs) by live HeLa cells. For this, AuNPs and AuNRs, surface ligated with a multicoordinating polymer that presents several amine groups per ligand, are simultaneously reacted with SVS-1 and Texas-Red dye; the latter allows fluorescence visualization of the nanocrystals. Using epifluorescence microscopy, we find that incubation of the SVS-1-conjugated AuNPs and AuNRs with a model cancer cell line yields extended staining throughout the cell cytoplasm, even at low conjugate concentrations (∼0.1 nM). Furthermore, uptake is specific to the SVS-1-conjugated nanocrystals. Additional endocytosis inhibition experiments, where cells have been incubated with the conjugates at 4 °C or in the presence of endocytic inhibitors, show that significant levels of conjugate uptake persist. These results combined indicate an uptake mechanism that does not necessarily rely on endocytosis, a promising finding with implications for the use of nanomaterials in the field of biology and nanomedicine.

Identifiers

PMID30411018
PMCPMC6210078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.